SCHEMBL7307514

SCHEMBL7307514

COCCOCCOc1ccc(-c2nn[c]o2)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 10/20 0.40
RECQL P46063 1/20 0.40
ALDH1A1 P00352 8/20 0.39
NPC1 O15118 7/20 0.39
RAB9A P51151 7/20 0.39
HPGD P15428 7/20 0.39
HSD17B10 Q99714 6/20 0.39
SMN1; SMN2 Q16637 6/20 0.39
MAPT P10636 4/20 0.39
TSHR P16473 3/20 0.39
LMNA P02545 1/20 0.39
S1PR1 P21453 1/20 0.38
CHEK1 O14757 1/20 0.37
L3MBTL1 Q9Y468 1/20 0.36
CYP2C9 P11712 2/20 0.36
CYP2C19 P33261 2/20 0.36
POLB P06746 1/20 0.36
APP P05067 1/20 0.36
TP53 P04637 4/20 0.35
RARB P10826 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7307355 0.80 RAB9A (0.54) KDM4EALDH1A1NPC1RAB9AHPGD
SCHEMBL22965412 0.77 KDM4E (0.56) KDM4ERECQLALDH1A1SMN1; SMN2MAPT
SCHEMBL12703538 0.74 KDM4E (0.61) KDM4ERECQLMAPTCHEK1L3MBTL1
SCHEMBL3611926 0.74 KDM4E (0.61) KDM4ERECQLMAPTCHEK1L3MBTL1
SCHEMBL13554406 0.71 CYP3A4 (0.50) KDM4ERECQLMAPTCHEK1CYP2C9
SCHEMBL9809214 0.71 LSS (0.54) KDM4ERECQLALDH1A1NPC1RAB9A
SCHEMBL16234547 0.71 KDM4E (0.50) KDM4ERECQLALDH1A1MAPTCHEK1
SCHEMBL15561455 0.71 LSS (0.54) KDM4ERECQLALDH1A1NPC1RAB9A
SCHEMBL21025623 0.71 KDM4E (0.50) KDM4ERECQLALDH1A1NPC1HPGD
SCHEMBL17879939 0.69 APP (0.59) KDM4ERECQLALDH1A1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5371074-A Use of saccharin derivatives as proteolytic enzyme inhibitors STERLING WINTHROP INC. (US) 1994-12-06 US claimed
EP-0542372-A1 2-Substituted saccharin derivative proteolytic enzyme inhibitors STERLING WINTHROP INC. (US) 1993-05-19 EP claimed
US-5578623-A DRUGS FOR TREATMENT OF ARTHRITIS, PANCREATITIS, CYSTIC FIBROSIS, BRONCHITIS, RESPIRATORY DISORDERS STERLING WINTHROP INC. (US) 1996-11-26 US disclosed
US-5464852-A Used in treatment of degenerative diseases STERLING WINTHROP INC. (US) 1995-11-07 US disclosed
US-5380737-A Enzyme inhibitors STERLING WINTHROP INC. (US) 1995-01-10 US disclosed
EP-0542371-A1 Saccharin derivative proteolytic enzyme inhibitors STERLING WINTHROP INC. (US) 1993-05-19 EP disclosed